-
181
-
182
Therapeutic benefit of the dual ALK/FAK inhibitor ESK440 in ALK-driven neuroblastoma
Published 2025-02-01Get full text
Article -
183
-
184
-
185
-
186
Unraveling complexity and leveraging opportunities in uncommon breast cancer subtypes
Published 2025-01-01Get full text
Article -
187
-
188
History and Habitability of the LP 890-9 Planetary System
Published 2025-01-01Get full text
Article -
189
-
190
A Randomized Placebo-Controlled Dose-Response Trial of Muvz™ for Knee and Low-Back Support in Physically Active Adults
Published 2025-02-01“…Douglas Kalman,1 Shalini Srivastava,2 Ajinkya Desale,3 Manish Devidas Chatte Snr,4 Rohit J Nalavade,5 Kshitij Manoj Shah Snr,6 Sagar Karvir,7 Surendra Bhasale8 1Department of Nutrition, Dr. …”
Get full text
Article